{"altmetric_id":4688771,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Prism Pharma Co., Ltd."],"first_seen_on":"2015-10-28T12:56:26+00:00","isbns":[],"issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1503084002,"links":["http:\/\/clinicaltrials.gov\/show\/NCT01302405","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01302405"],"nct_id":"NCT01302405","pubdate":"2011-02-18T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors","type":"clinical_trial_study_record"},"altmetric_score":{"score":7.25,"score_history":{"1y":0.25,"6m":0.25,"3m":0.25,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.25},"context_for_score":{"all":{"total_number_of_other_articles":8392157,"mean":7.0686031077041,"rank":1205202,"this_scored_higher_than_pct":85,"this_scored_higher_than":7179077,"rank_type":"exact","sample_size":8392157,"percentile":85},"similar_age_3m":{"total_number_of_other_articles":245764,"mean":9.7898775486952,"rank":44784,"this_scored_higher_than_pct":81,"this_scored_higher_than":200692,"rank_type":"exact","sample_size":245764,"percentile":81},"this_journal":{"total_number_of_other_articles":24677,"mean":10.537349813584,"rank":4039,"this_scored_higher_than_pct":83,"this_scored_higher_than":20588,"rank_type":"exact","sample_size":24677,"percentile":83},"similar_age_this_journal_3m":{"total_number_of_other_articles":1126,"mean":14.861816888889,"rank":225,"this_scored_higher_than_pct":79,"this_scored_higher_than":900,"rank_type":"exact","sample_size":1126,"percentile":79}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}},"geo":{"twitter":{"CA":1}}},"counts":{"total":{"posts_count":4},"blogs":{"unique_users_count":1,"unique_users":[57867],"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["drugtrialsbot"],"posts_count":2}},"posts":{"blogs":[{"title":"Targeting the Wnt Pathway [7.11]","url":"http:\/\/pharmaceuticalintelligence.com\/2015\/04\/10\/targeting-the-wnt-pathway-7-11\/","license":"public","citation_ids":[3899836,3899836,2733666,2733666,2733666,4688771,3899842,3899842,3899843,3899843,3899847,3899847,3899847,1739772,1739772,3899855,3899855],"posted_on":"2015-04-11T00:54:00+00:00","summary":"Targeting the Wnt Pathway Writer and Curator: Larry H Bernstein, MD, FCAP&nbsp; &nbsp; 7.11 Targeting the Wnt Pathway 7.11.1 Targeting the Wnt pathway in human cancers. Therapeutic targeting with a focus on OMP-54F28 Le PN, McDermott JD, Jimeno A. Pharmaco","author":{"name":"Pharmaceutical Intelligence","url":"http:\/\/pharmaceuticalintelligence.com\/","description":"A blog specializing in Pharmaceutical Intelligence and Analytics"}},{"title":"Targeting Epithelial To Mesenchymal Transition (EMT) As A Therapy Strategy For Pancreatic Cancer","url":"https:\/\/pharmaceuticalintelligence.com\/2016\/04\/19\/targeting-emt-as-a-therapy-strategy-for-pancreatic-cancer\/","license":"public","citation_ids":[6819187,6819188,6819190,3224841,3607780,4780776,6819194,4218828,6819197,2742309,4688771,6819199],"posted_on":"2016-04-19T12:33:00+00:00","summary":"In summary a number of EMT pathway targeting therapeutics are in development which have the potential to target pancreatic cancer stem cells, which could reduce cancer recurrence, and deplete the cancer associated stroma which should improve the penetrance","author":{"name":"Pharmaceutical Intelligence","url":"http:\/\/pharmaceuticalintelligence.com\/","description":"A blog specializing in Pharmaceutical Intelligence and Analytics"}}],"twitter":[{"url":"http:\/\/twitter.com\/drugtrialsbot\/statuses\/898258133860048896","license":"gnip","citation_ids":[4688771],"posted_on":"2017-08-17T19:00:02+00:00","author":{"name":"Drug Trials Bot","url":"http:\/\/www.bgcarlisle.com\/montreal\/tag\/bioethics\/","image":"https:\/\/pbs.twimg.com\/profile_images\/2958456887\/1b81f1c3e60ea18e093a865f1760d576_normal.jpeg","description":"I tweet the reason when a drug trial is suspended, terminated or withdrawn\n\nInspired this paper: http:\/\/journals.sagepub.com\/doi\/abs\/10.1177\/1740774514558307","id_on_source":"drugtrialsbot","tweeter_id":"996279691","geo":{"lt":45.50884,"ln":-73.58781,"country":"CA"},"followers":14},"tweet_id":"898258133860048896"},{"url":"http:\/\/twitter.com\/drugtrialsbot\/statuses\/898625553451724800","license":"gnip","citation_ids":[4688771],"posted_on":"2017-08-18T19:20:02+00:00","author":{"name":"Drug Trials Bot","url":"http:\/\/www.bgcarlisle.com\/montreal\/tag\/bioethics\/","image":"https:\/\/pbs.twimg.com\/profile_images\/2958456887\/1b81f1c3e60ea18e093a865f1760d576_normal.jpeg","description":"I tweet the reason when a drug trial is suspended, terminated or withdrawn\n\nInspired this paper: http:\/\/journals.sagepub.com\/doi\/abs\/10.1177\/1740774514558307","id_on_source":"drugtrialsbot","tweeter_id":"996279691","geo":{"lt":45.50884,"ln":-73.58781,"country":"CA"},"followers":14},"tweet_id":"898625553451724800"}]}}